Aclaris Therapeutics (ACRS)
$2.57 2.4%
to add to portfolio
AI Score
-
Alternative
3 -
Fundamental
2 -
Technical
6
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Aclaris Therapeutics, AI stock picks, stock alerts and much more.
ACRS AI Stock Analysis
AI stock analysis for ACRS is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Aclaris Therapeutics (ACRS) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
ACRS Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Aclaris Therapeutics (ACRS), currently trading at $2.57, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About ACRS
-
Aclaris Therapeutics, Inc.
-
Symbol
ACRS
-
Market
NASDAQ
-
Industry
Medical - Diagnostics & Research
-
Market Cap
275M
Similar Stocks
 |
Bionano Genomics BNGO |
$0.1934 5.9% |
1 |
 |
23andMe ME |
$3.61 0.00% |
3 |
 |
Illumina ILMN |
$136.7 0.5% |
3 |
 |
Neogen NEOG |
$11.56 0.3% |
5 |
 |
DarioHealth DRIO |
$0.694 6.7% |
4 |
News
ACRS Alternative Data
News Mentions
Sign up to access
LinkedIn Followers
Sign up to access
Job Postings
Sign up to access
LinkedIn Employees
Sign up to access
Web Traffic
Sign up to access
Business Outlook
Sign up to access
ACRS Financials
ACRS Key Metrics
-
Total Revenue
$4.3M
-
Net Income
-$7.6M
-
Earnings per Share
-$0.11
-
Free cash flow
$22M
-
EBITDA
-$10.5M
-
EBITDA Ratio
-2.40934
-
Total Assets
$182.4M
ACRS 2-year Revenue & Income
ACRS 2-year Free Cash Flow
ACRS Technicals
ACRS SMA
ACRS RSI
FAQ
What's the current price of Aclaris Therapeutics (ACRS) Stock?
The price of an Aclaris Therapeutics (ACRS) share is $2.57.
What's the market cap of Aclaris Therapeutics?
The current market cap of Aclaris Therapeutics is 275M.
Should I buy or sell ACRS?
Aclaris Therapeutics exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.
Is Aclaris Therapeutics a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Aclaris Therapeutics stock. There are several bearish signals and market challenges that could negatively impact Aclaris Therapeutics' future performance, suggesting that caution should be exercised before making any investment decisions.
Is now a good time to buy Aclaris Therapeutics (ACRS) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Aclaris Therapeutics stock right now, as the outlook appears bearish.
What are some stocks similar to Aclaris Therapeutics (ACRS) that investors often compare it to?
Aclaris Therapeutics (ACRS) is often compared to similar stocks such as Bionano Genomics, 23andMe, Illumina, Neogen and DarioHealth.
What is the forecast for Aclaris Therapeutics' stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Aclaris Therapeutics' stock price to be around $2.36 in 2026. Starting from the current price of $2.57, this represents a 8.1% change in price, indicating a bearish outlook for the stock.
How to buy Aclaris Therapeutics (ACRS) Stock?
Aclaris Therapeutics stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Aclaris Therapeutics shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.